Generic Drug Tariffs: US President Trump outlined a phased tariff plan for imported generics—zero through Aug 2026, then 100% in 2028 and 200% in 2029—aimed at pushing “reshoring” of generic manufacturing, raising concerns about shortages and higher costs for patients. China Pharma Supply Chain Exposure: Reporting notes China’s dominance in upstream active ingredients means the impact could reach beyond finished-product exporters, putting pressure on regional pharma supply networks. Regulatory & Market Moves: Novo Nordisk sued Eli Lilly over alleged misleading GLP-1 ads, while Haisco’s ciprofol (Cipepofol) cleared the US FDA with Jiuzhou Pharma CDMO support—another sign of China-made anesthesia innovation pushing into Western markets. Infectious Disease Watch (Macau): Macau reported 2,755 notifiable cases in June; influenza led, with big month-on-month jumps in enterovirus, norovirus, and scarlet fever. COVID Update (Taiwan): Taiwan entered a new COVID epidemic phase as weekly cases rose 66.5%, with health authorities urging hygiene, masks in healthcare, and vaccination. Heat Safety (Macau): A yellow heat alert prompted warnings on heatstroke and related illnesses, including heat exhaustion and cramps. Healthcare Access Policy: Bangladesh plans a “National Health Card” to reduce the urban-rural gap by enabling doctors to access records nationwide. Tech for Care: WAIC-linked news highlights AI and enterprise health applications, including new healthcare AI solutions and AI-driven initiatives.